The best of Cambridge UK life science businesses are making encouraging headway commercially in the US and ذكذكتسئµâ€™s latest move looks set to provide another â€کwow’ moment on both sides of the Pond.
ذكذكتسئµ has just hired biopharma industry class act Christine Silverstein as Chief Financial Officer. As CEO Niall Martin remarks, her track record of raising capital, preparing companies for IPO and experience with partnerships and M & A will position ذكذكتسئµ for success as it continues to advance its leading DNA damage response (DDR) pipeline.
To read more: